University of California San Francisco

Clinical Trials

Data provided by UCSF Profiles, powered by CTSI
Clinical Trial Principal Investigator Related Conditions
US National OCS Liver Perfusion (OLP) Registry
Study Id: NCT05940857
Start Date: - End Date:
  • Liver Transplant
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Study Id: NCT06263426
Start Date: - End Date:
  • HIV/AIDS
  • Kidney Transplant
  • Immunodeficiency
KIDney Injury in Times of COVID-19 (KIDCOV)
Study Id: NCT04705766
Start Date: - End Date:
  • COVID-19
  • Acute Kidney Injury
  • Kidney Injury
  • Severe Acute Respiratory Syndrome
Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction
Study Id: NCT02474199
Start Date: - End Date:
  • Liver Transplant
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Study Id: NCT02188719
Start Date: - End Date:
  • Liver Transplant
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Study Id: NCT02188719
Start Date: - End Date:
  • Liver Transplant
Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )
Study Id: NCT02244801
Start Date: - End Date:
  • Kidney Disease
  • Kidney Transplant